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Effects of Novel Taxanes SB-T-1213 and IDN5109
on Tubulin Polymerization and Mitosis
taxane, paclitaxel, as well as greater aqueous solubility
and the maintenance of high potency in non-MDR-
expressing cancer cells [3–9].
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Leslie Wilson,1 Giovanni Scambia,3
and Cristiano Ferlini3 The two novel taxanes, SB-T-1213 and IDN5109 (Fig-
ure 1), were synthesized from 10-deacetylbaccatin III1Department of Molecular, Cellular,
and Developmental Biology and and 14-hydroxy-10-deacetylbaccatin III isolated from
Taxus baccata and Taxus walichiana Zucc., respec-The Neuroscience Research Institute
University of California Santa Barbara tively. SB-T-1213 differs from paclitaxel (Figure 1) at the
10 and 3 positions, and IDN5109 differs from paclitaxelSanta Barbara, California 93106
2 Department of Chemistry at the 3 and 1,14 positions. Because such structural
alterations could change the primary mechanism of ac-State University of New York at Stony Brook
Stony Brook, New York 11794 tion, it was necessary to determine whether these com-
pounds have similar effects on tubulin, microtubules,3Department of Obstetrics and Gynecology
Universita` Cattolica Sacro Cuore and cell functions as does the prototype taxane, pacli-
taxel.00165 Rome
Italy Paclitaxel binds reversibly to microtubules in vitro, stim-
ulates microtubule polymerization, and promotes both the
nucleation and elongation phases of the polymerization
reaction [10]. Suppressing microtubule dynamic instabilitySummary
and treadmilling, the drug strongly stabilizes microtubules
[11, 12]. It increases the microtubule polymer mass atSB-T-1213 and IDN5109 are semisynthetic, orally
high concentrations by suppressing tubulin dissociationavailable taxanes that are up to 400-fold more active
at microtubule ends while the ends remain free for tubulinthan paclitaxel against drug-resistant cells. IDN5109
addition [12]. High concentrations of paclitaxel have theis in clinical trials. We investigated the primary target
unique ability to cause microtubules to arrange into par-for SB-T-1213 and IDN5109 and whether the com-
allel bundles in cells [13]. However, at low concentra-pounds interact with microtubules differently than
tions paclitaxel strongly inhibits cell proliferation bypaclitaxel. Unlike paclitaxel, at 1–10 M both novel
blocking cell cycle progression specifically at the meta-taxanes initiate microtubule polymerization in vitro
phase/anaphase transition while exerting no discerniblewith no lag. They enhance polymerization equally or
effects on the microtubule polymer mass and only subtlemore potently than paclitaxel. SB-T-1213 induces un-
effects on mitotic spindle microtubule organization, ulti-usual microtubules with attached extra protofilaments
mately leading to apoptosis [14–16].or open sheets, and IDN5109 induces large protofila-
SB-T-1213 is 135-fold more active than paclitaxelmentous sheets. Both inhibit HeLa cell proliferation,
against MCF-7-R cells, a doxorubicin-resistant cell lineblock mitosis at the metaphase/anaphase transition,
that expresses the multidrug resistance gene MDR, andbundle microtubules at high drug concentrations, and
it is 5- to 11-fold more effective than paclitaxel againstinduce abnormal metaphase spindles and apoptosis.
a number of other human cell lines and human tumorThey target microtubules but alter their polymerization
xenografts [3, 6]. It inhibits the function of the MDR-and structure differently than paclitaxel. These differ-
associated Pgp-efflux pump [6], is orally available, andences may play a role in their enhanced cytotoxicity
is currently undergoing extensive animal studies.and efficacy.
IDN5109, currently in clinical trials, is as much as 440-
fold more active than paclitaxel against adriamycin-
Introduction resistant and vinblastine-resistant breast and leukemia
cells [4, 6], is orally active in tumor models with excellent
Taxanes are among the most important cancer chemo- bioavailability (48%–50.5%), appears to have reduced
therapeutic agents to have been developed in recent neuro- and other toxicities, and has recently been shown
times. Although they are effective in the treatment of to act as a Pgp reversal agent [7–9].
many types of cancer, including carcinomas of the As a result of the promising activities of SB-T-1213
ovary, lung, head and neck, bladder, and esophagus [1], and IDN5109, we have investigated their interactions
their therapeutic use is often associated with undesired with microtubules in vitro and in cells. We find that both
toxic side effects as well as the development of multi- novel taxanes enhance the polymerization of bovine
drug resistance (MDR) [2]. Thus, two analogs were syn- brain tubulin in vitro as well as or more potently than
thesized with the goal of developing taxanes that were paclitaxel but that they induce the formation of unusual
more water-soluble and more active in MDR-expressing tubulin polymers, suggesting that they bind to and affect
cancer cells. The two new analogs described here, SB- the conformation and polymerization of tubulin differ-
T-1213 and IDN5109, show significantly higher antitu- ently than paclitaxel. In HeLa cells, the novel drugs in-
mor activity in MDR-bearing tumor cells than the classic duce aberrant mitotic spindles, block mitosis at the tran-
sition from metaphase to anaphase, induce microtubule
bundling at high concentrations, and induce apoptosis.4Correspondence: jordan@lifesci.ucsb.edu
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Figure 1. Structural Formulas of SB-T-1213, IDN5109, and Paclitaxel
The results indicate that although these compounds in- by sedimentation, a method that is independent of differ-
ences in the shape of the polymers formed. Bovine brainteract somewhat differently with tubulin and its poly-
mers, they share the basic microtubule-targeted antitu- tubulin (1.0–1.4 mg/ml, 0.1 mM GTP, 37C) was incu-
bated with a range of concentrations of SB-T-1213,mor mechanism of the taxanes but have, in addition,
the capacity to overcome multidrug resistance. IDN5109, or paclitaxel (10 nM–3 M) for 20 min, and
the resulting polymer was collected by centrifugation
(Experimental Procedures). The extent of polymerizationResults
was determined by measuring the reduction in soluble
tubulin in the supernatant and comparing it with controlSB-T-1213 and IDN5109 Induced Polymerization
of Tubulin In Vitro More Potently Than Paclitaxel supernatants, as shown in Figure 2B. Both the novel
taxane analogs and paclitaxel increased the amount ofSB-T-1213 and IDN5109 both stimulated polymerization
of tubulin more potently than paclitaxel. Figure 2A shows polymerized tubulin in the pellets (reduced the soluble
tubulin) in concentration-dependent manners. SB-T-a representative time course of bovine brain tubulin as-
sembly as measured turbidimetrically in the presence 1213 was 30% more potent than paclitaxel at reducing
the tubulin remaining in the supernatant, whereasof 1 and 10 M of the three taxanes. In the control,
no significant tubulin polymerization occurred (lowest IDN5109 was equivalent in potency to paclitaxel. The
EC50 value for reduction in soluble tubulin was 0.07 Mcurve) because the tubulin concentration was at or be-
low the critical concentration for polymerization. At 10 for SB-T-1213, as compared with 0.10 M for both
IDN5109 and paclitaxel.M (upper three curves), turbidity increased immedi-
ately upon the addition of either SB-T-1213 (dashed line) We examined whether the assembly induced by high
concentrations of SB-T-1213 and IDN5109 yielded au-or IDN5109 (solid line) to tubulin, whereas a slight lag
occurred after the addition of paclitaxel (dotted line). At thentic microtubule polymers, as opposed to non-spe-
cific drug/tubulin aggregates or precipitates, by using10M, SB-T-1213 and IDN5109 enhanced turbidity 58%
and 24% more, respectively, than paclitaxel (mean of negative-stain electron microscopy. As shown in Fig-
ures 3A–3D, both novel taxanes induced the formation3–4 experiments). At a lower concentration (1 M), SB-
T-1213 (lower dashed line) and IDN5109 (lower solid line) of protofilamentous polymers. With IDN5109 (1–10 M),
the predominant polymers were loops or thick fibers ofenhanced turbidity 112% and 75% more, respectively,
than paclitaxel (lower dotted line). Even with lower con- a few or many protofilaments (arrows in Figure 3A), large
protofilamentous sheets of varying width (sometimes ascentrations of SB-T-1213 and IDN5109 (1M), there was
no lag before the onset of polymerization, whereas with large as 30 protofilaments in width) (arrows in Figure
3B), and only rare microtubules. With SB-T-1213 (1–101 M paclitaxel the lag was 3–5 min.
The polymers induced by each of the three drugs were M), microtubules generally predominated; however, a
large number of the microtubules had several extra pro-stable in cold to approximately the same degree. After at
least 20 min of cooling on ice, 71%–88% of the turbidity tofilaments or partial microtubules associated linearly
(asterisks in Figure 3D), coils of several protofilamentsinduced by 10 M of each of the three drugs and 30%–
40% of the turbidity induced by 1 M of each of the (“C”), or significant sections of unclosed sheet (arrows
in Figures 3C and 3D). In contrast, with paclitaxel (1–10three taxanes remained (data not shown).
The mass of polymerized tubulin was also determined M), microtubules (“M”; Figures 3E and 3F) were by far
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ity was inhibited at concentrations of 1.1  0.6 nM with
SB-T-1213, 1.9  0.8 nM with IDN5109, and 3.7  1.1
nM with paclitaxel. Thus the IC50 values for inhibition of
clonogenicity were very similar to those obtained in the
short-term growth inhibition experiments.
SB-T-1213 and IDN5109 Blocked Cell-Cycle
Progression at the Metaphase/Anaphase
Transition
The mitotic index was determined after a 20 hr incuba-
tion with a range of concentrations of the novel com-
pounds. As shown in Figure 4 (left axis, open circles),
SB-T-1213 at 6 nM induced 50% mitotic block, and 30
nM induced 90% mitotic block. With IDN5109, 10 nM
induced 50% mitotic block and 60 nM induced 90%
mitotic block (open squares). We previously found that
8 nM paclitaxel induced 50% mitotic block in HeLa cells,
and 30–100 nM induced 80%–90% mitotic block [14].
We examined the ratio of cells in anaphase to cells
in metaphase to determine if, like paclitaxel, the novel
taxanes block mitosis specifically at the transition from
Figure 2. Enhancement of Tubulin Polymerization by SB-T-1213, metaphase to anaphase. As shown in Figure 4 (right
IDN5109, and Paclitaxel axis, filled symbols), the anaphase/metaphase ratio de-
(A) Time course of polymerization as measured by turbidimetry at creased in a concentration-dependent manner, from
350 nm. Dashed lines represent SB-T-1213 at 10 M (upper) and 1
0.31 in controls (in the absence of compound) to 0.03M (lower); solid lines represent IDN5109 at 10 M (upper) and 1
at 3 nM SB-T-1213 and 0.05 at 3 nM IDN5109. No cellsM (lower); and dotted lines represent paclitaxel at 10 M (upper)
were detected in anaphase at concentrations of moreand 1 M (lower). The flat line with alternating dots and dashes
represents the control. Polymerization was conducted as described than 10 nM for SB-T-1213 or IDN5109. Paclitaxel gave
in the Experimental Procedures with 13–14 M tubulin and the indi- similar results; the anaphase/metaphase ratio de-
cated drug concentration. creased to 0.01 at 10 nM drug, and no cells were de-
(B) Unpolymerized tubulin remaining after incubation with each of
tected in anaphase at higher concentrations [14].the three taxanes is presented as a percentage of unpolymerized
tubulin in controls (no drug). In other words, the graph shows the
concentration dependence for reduction in soluble tubulin by
Low Concentrations of SB-T-1213 and IDN5109IDN5109, SB-T-1213, and paclitaxel as measured by the sedimenta-
Induced Abnormal Spindle and Nucleartion of polymer. Tubulin (10–14 M) was incubated with a range
of concentrations of the three taxanes (SB-T-1213, open circles; Morphology
IDN5109, closed circles; paclitaxel, open squares) at 37C for 20 min Very low concentrations of the taxane analogs induced
and centrifuged to sediment polymer (Experimental Procedures). distinct disruptions of microtubule spindle morphology
Tubulin remaining in the supernatants was compared with tubulin and nuclear organization that strongly resembled those
in supernatants of reaction mixtures incubated in the absence of a
induced by paclitaxel. In control HeLa cells in meta-drug. Without a drug, there was no reduction in soluble protein after
phase, spindles were bipolar with a compact, densecentrifugation, and no visible pellet formed. Results are presented
as a percent of control supernatant protein values and are the mean plate of condensed chromosomes (Figures 5A and 5B).
and SE of four independent experiments. Very low concentrations of either analog (as low as 1
nM) induced the formation of predominantly multipolar
multiastral spindles with disorganized arrays of chromo-
the predominant form, and only a few sheets and loops somes (Figures 5C–5F). In bipolar spindles, individual
were formed. Thus, SB-T-1213 induced a greater poly- chromosomes were frequently associated with only one
mer mass than paclitaxel, and the polymers were some- spindle pole, indicating that the chromosomes were un-
what less normal. IDN5109 induced the same polymer able to achieve a normal bipolar attachment to the spin-
mass as paclitaxel by sedimentation, but the polymers dle and thus were unable to congress to the metaphase
were extremely aberrant. plate (Figures 5C and 5D).
SB-T-1213 and IDN5109 Inhibited HeLa Cell
Proliferation More Potently Than Paclitaxel High Concentrations of SB-T-1213 and IDN5109
Induced Microtubule Bundling in CellsTo determine whether the effects of the novel taxanes
on microtubule polymerization resulted in differences in In control HeLa cells during interphase, microtubules
formed a fine network of unaligned microtubules (Figuretheir cellular mechanisms of action, we examined their
actions in HeLa cells, a cell line for which we have exten- 6A). As shown in Figures 6B and 6C, 10 nM SB-T-1213
and 30 nM IDN5109 induced the formation of small,sive experience with paclitaxel. Proliferation was inhib-
ited by 50% (IC50) at concentrations of 2.3 0.6 nM with loose bundles of parallel microtubules. At more than 30
nM of either compound, microtubule bundles were large,SB-T-1213, 1.8  0.5 nM with IDN5109, and 4.8  0.9
nM with paclitaxel (72 hr). Clonogenic assays indicated compact, and prominent (data not shown). Thus, like
paclitaxel, at high concentrations both novel taxanesthe absence of additional long-term effects; clonogenic-
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Figure 3. Tubulin Polymers Induced by 1 M IDN5109 or 1 M SB-T-1213, as Compared with Paclitaxel
Electron micrographs; left column, low magnification; right column, high magnification. IDN5109 (A and B) induced the formation of large
bundles of fibers (asterisk), large sheets (arrows), and a few microtubules. SB-T-1213 (C and D) induced the formation of microtubules (M)
and a few sheets (arrows), partial microtubules, loops and coils (C), and long regions of a small number of protofilaments associated linearly
with microtubules. Paclitaxel (1 M) (E and F) induced the formation of many microtubules (M) and few sheets or loops. The scale bar in (A)
represents 500 nm; that in (B) represents 100 nm. (A), (C), and (E) are at the same magnification, as are (B), (D), and (F).
induced formation of bundles of microtubules or tubulin bers of interphase cells were multinucleate (32.6% and
29.9%, respectively). The proportion of multinucleatedpolymers (see below).
An important characteristic of paclitaxel’s actions is interphase cells increased with increasing compound
concentration, reaching levels greater than 70% andthat many cells become multinucleate after incubation
for 20 hr with low concentrations of the drug (Table 1; greater than 60% at 10–30 nM SB-T-1213 and IDN5109,
respectively. The proportions of multinucleated cells de-[16]). This phenomenon occurred to an even greater
degree with the two novel taxane analogs; that is, the creased at concentrations of more than 30 nM SB-T-
1213 or IDN5109 and more than 10 nM paclitaxel.proportions of multinucleate cells reached levels as high
as 60% and 70% (Table 1). In control cells in interphase, At the lowest concentrations (0.3–1 nM), multinucle-
ated cells contained from 2 to 4 nuclei, whereas at moreonly 2.7  0.6% contained more than one nucleus. At
concentrations of SB-T-1213 as low as 0.3 nM and at than 3 nM, the number of nuclei was often as great as
5–10 per cell. In addition, after incubation for 20 hr withconcentrations of IDN5109 as low as 1 nM, large num-
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Figure 4. Taxane Concentration Dependence for Mitotic Arrest and
Block at the Metaphase/Anaphase Transition
Mitotic index (left axis; SB-T-1213, open circles; IDN5109, open
squares); ratio of cells in anaphase to cells in metaphase (right axis;
SB-T-1213, filled circles; IDN5109, filled squares). HeLa cells were
incubated with taxane for 20 hr, then fixed and stained for microtu-
bules and chromatin (Experimental Procedures). The numbers of
cells in metaphase and anaphase were counted by microscopy.
Values are the mean SE of 4–5 experiments and represent counts
from at least 50 mitotic cells/concentration in each experiment and
100 interphase cells/concentration per experiment.
3 nM of either analog, the sizes of the resulting cells
varied considerably, and occasionally, grape-like clus-
ters of attached small cells occurred. These clusters
appeared to result from incomplete cytokinesis (Figures
5E and 5F). Cell clustering, the varying sizes of cells,
multinucleation, and the abnormality of nearly all spin-
Figure 5. Induction of Abnormal Spindles by SB-T-1213 and
dles suggested that many cells underwent an abnormal IDN5109
mitosis and reentered interphase without completing
HeLa cells incubated with no drug (A and B), 1 nM SB-T-1213 (C
cytokinesis, as observed previously with paclitaxel [16]. and D), or 3 nM IDN5109 (E and F) for 20 hr, followed by fixation
The decrease in the proportion of multinucleated cells and staining for tubulin (A, C, and E) and chromosomes (B, D, and
F). In the absence of drug (A and B), metaphase spindles are bipolarat higher drug concentrations may result from a more
with compact metaphase plates of chromosomes (arrow). At lowpotent and enduring mitotic block in the presence of
concentrations of SB-T-1213 (1 nM), spindles are bipolar or multipo-high drug concentrations.
lar (arrow in C), and chromosomes often fail to congress to the
metaphase plate and instead remain at the poles (arrows in D). At
low concentrations of IDN5109, similar abnormalities occur. TwoSB-T-1213 and IDN5109 Induced Apoptosis at the multipolar spindles (arrows in E) as well as one cluster of three small
Same Concentrations That Induced Mitotic Block cells resulting from an aberrant incomplete cytokinesis (arrows in
By TUNEL assay, as shown in Figure 7A, incubation of F) are shown in (E) and (F). The resulting cells are multinucleate
(arrows in F). The scale bar represents 10 m.HeLa cells with the novel taxanes at concentrations as
low as 2.5 nM for 24 hr induced apoptosis. Higher con-
centrations of paclitaxel (5 nM; Figure 7B) were required
for induction of apoptosis. The percentage of cells that Discussion
were apoptotic reached 70% with 5 nM SB-T-1213 and
40% with 5 nM IDN5109 at 24 hr. These data indicate that We find that SB-T-1213 and IDN5109 induce tubulin
polymerization significantly differently from paclitaxel,apoptosis was strongly correlated with mitotic block.
Figure 8 shows the 24 hr time course for induction of both in the rate and extent of polymerization and in the
morphology of the polymers formed. SB-T-1213 stimu-apoptosis by 5 nM SB-T-1213 as determined by flow
cytometry analysis that combined results of the TUNEL lated tubulin polymerization in vitro with little or no lag
of initiation (Figure 2A). By turbidimetry, SB-T-1213 (1assay (anti-BrDu FITC fluorescence) with the assay of
cellular DNA content. The numbers in the lower right of and 10M) enhanced polymerization by 58% and 112%,
respectively, more than paclitaxel. By sedimentation,each panel indicate the percentage of cells that were
apoptotic (having high anti-BrDu FITC fluorescence and SB-T-1213 was 30% more potent than paclitaxel in re-
ducing the concentration of soluble tubulin (Figure 3B).lying above the diagonal line). The data indicate that
most apoptotic cells arise from cells that remain blocked Thus, it is clear by both methods of measuring polymer
mass that SB-T-1213 induces tubulin polymerizationin the G2/M stage of the cell cycle or from cells blocked
in G2/M that subsequently reenter interphase without significantly more than paclitaxel. Microtubules were the
predominant product of the induced assembly reaction,undergoing cytokinesis.
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Figure 6. Microtubule Bundling Induced by
High Concentrations of SB-T-1213 and
IDN5109
Control HeLa cells (A) exhibit a normal mesh-
work of fine microtubules in interphase. After
a 20 hr incubation with 30 nM SB-T-1213 (B)
and 30 nM IDN5109 (C), bundles of microtu-
bules are clearly evident (arrows). The scale
bar represents 22 m.
although sheets and partial microtubules were also to the interior surface of microtubules, in a 1:1 stoichiom-
etry with tubulin in the microtubules [17–20]. Paclitaxelcommonly formed (Figure 3). Paclitaxel also induced the
formation of sheets, but they were fewer in number than preferentially induces microtubules with 12, rather than
13, protofilaments [21, 22]. Thus, paclitaxel appears towith SB-T-1213 and the microtubules induced by pacli-
taxel were of normal appearance, rather than having induce a slight reduction of the lateral contact curvature
between tubulin monomers in the microtubule. In thepartial microtubules or extra protofilaments associated
with them. cold or under rapid assembly conditions, paclitaxel in-
duces the formation of some hoops and sheets as wellIDN5109 also potently stimulated tubulin polymeriza-
tion in vitro with no detectable lag. The turbidimetric as microtubules. The observation that SB-T-1213 and
IDN5109 induce formation of more non-microtubulesignal reached significantly higher levels than with pacli-
taxel (1 and 10 M IDN5109, 24% and 75% higher than polymers than paclitaxel can not be taken as evidence of
the intracellular polymer morphology induced by thesepaclitaxel, respectively; Figure 2A). However, since pre-
dominantly large sheets were formed, it is possible that drugs; rather, the results indicate that these novel drugs
interact differently with tubulin and microtubules thanthe turbidimetric signal over-represented the true mass
of polymer induced by IDN5109. This is supported by paclitaxel. The most potent effect of all three drugs in
cells appears to involve mitotic block, which likely re-the observation that the reduction of soluble tubulin
by IDN5109 equals that of paclitaxel in centrifugation sults from suppression of microtubule dynamics and
leads to apoptosis. The differing effects of the novelexperiments (EC50 of 0.1 M for both paclitaxel and
IDN5109; Figure 8B). It should be mentioned that it is taxanes on the polymerization of brain tubulin in vitro
indicate that they are likely to affect microtubule polymerconceivable that the absence of a lag in initiation of
the turbidimetric increase with both novel drugs might formation and dynamics in cells differently than pacli-
taxel.reflect a difference in the morphology of the polymer
formed at early time points. Overall, we found that both We found that SB-T-1213 and IDN5109 inhibited HeLa
cell proliferation, blocked mitosis, and induced apopto-novel taxanes are equal or better than paclitaxel in their
ability to enhance tubulin polymerization, with SB-T- sis in mitotically blocked cells. They exhibit 2-fold
greater ability than paclitaxel to inhibit proliferation, with1213 exhibiting higher potency than IDN5109.
The marked tendency of IDN5109 and SB-T-1213 to IC50 values of 2.3 nM for SB-T-1213 and 1.8 nM for
IDN5109 (Table 1), as compared with an IC50 for pacli-induce polymerization of tubulin into sheets and other
aberrant microtubule-like forms, in combination with the taxel of 4.8 nM. In addition, they induced apoptosis at
concentrations as low as 2.5 nM, whereas paclitaxelmore potent stimulation of assembly by SB-T-1213, sug-
gests that the novel taxanes induce conformational required a concentration of 5 nM to induce mitotic block
and apoptosis.changes in tubulin that differ significantly from the con-
formational changes induced by paclitaxel. Paclitaxel Like paclitaxel, at low concentrations (0.3 nM) both
novel taxanes induced abnormal metaphase spindlesbinds with low affinity to soluble vertebrate neuronal
tubulin and binds reversibly with high affinity, apparently with uncongressed chromosomes and inhibited mitosis
Table 1. Effects of SB-T-1213 and IDN5109 (20 hr Incubation) on Induction of Multinucleation in HeLa Cells
Multinucleate Cells (%)
Taxane Concentration (nM) SB-T-1213 IDN5109 Paclitaxel
0 (control) 2.7  0.6 2.7  0.6 2.7  0.7
0.3 32.6  9.2 9.6  0.9 3.2  1.2
1 41.6  7.6 29.9  9.0 11.6  4.0
3 60.4  11.5 49.0  17.5 32.1  17.9
10 71.4  2.1 59.8  8.2 37.7  11.5
30 71.9  5.3 60.4  13.1 16.5  4.5
100 28.1  6.5 31.1  19.1 14.0  6.8
300 49.9  22.1 23.9  10.0 n.a.
Mean and standard error of the mean for n  2–3 experiments. Data for paclitaxel are from [14].
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than paclitaxel against several drug-resistant cell
lines. Their potency combined with their improved
aqueous solubility, oral availability, and remarkable
lack of susceptibility to multidrug resistance mecha-
nisms indicates that they are strong candidates for
efficacious antitumor agents. SB-T-1213 and IDN5109
affect tubulin polymerization and microtubule struc-
ture differently from the classic taxane, paclitaxel, and
they are more potent than paclitaxel, even in cells such
as HeLa that are not multidrug resistant. In contrast
to paclitaxel, at 1–10 M both novel taxanes initiate
microtubule polymerization in vitro with no turbidimet-
ric lag and enhance polymerization equally or more
potently. SB-T-1213 induces the formation of unusual
microtubules with attached extra protofilaments or
open sheets, and IDN5109 induces large protofilamen-
tous sheets. The marked tendency of IDN5109 and SB-
T-1213 to induce the polymerization of tubulin into
sheets and other aberrant microtubule-like forms, in
combination with the more potent stimulation of as-
sembly by SB-T-1213, suggests that the novel taxanes
induce conformational changes in tubulin that differ
significantly from the conformational changes inducedFigure 7. Time Course for Induction of Apoptosis by SB-T-1213,
by paclitaxel. These differences in their interactionsIDN5109, and Paclitaxel
with tubulin and microtubules may play a direct role(A) 2.5 nM drug.
(B) 5 nM drug. in their enhanced cytotoxic potency and antitumor effi-
Apoptosis was measured by a TUNEL assay (see Experimental Pro- cacy. Their inhibition of HeLa cell proliferation, induc-
cedures). Error bars represent SD. tion of mitotic block with abnormal spindle formation,
bundling of microtubules at high drug concentrations,
and timing of induction of apoptosis from cells blocked
specifically at the transition from metaphase to ana- in mitosis all indicate that, like paclitaxel, their princi-
phase. In this respect the mechanisms of SB-T-1213 and pal target in tumor cells is microtubules.
IDN5109 resemble those of a number of microtubule-
Experimental Procedurestargeting drugs, including paclitaxel, vinca alkaloids,
colchicine, nocodazole, podophyllotoxin, dolastatin an-
Tubulin Purification and Microtubule Assemblyalogs, and the cryptophycins [23]. In addition, at some-
Bovine brain tubulin was purified by three cycles of polymerization
what higher concentrations (10–30 nM), both novel and depolymerization, followed by phosphocellulose chromatogra-
taxanes induced bundling of microtubules in interphase phy, and stored frozen at 70C [24]. The ability of the compounds
that resemble the bundles induced by paclitaxel [10, 14]. to enhance tubulin polymerization was determined in two ways: (1)
tubulin (1.0–1.4 mg/ml) was incubated with a range of drug concen-The novel taxanes also induced the formation of very
trations in assembly buffer (0.1 M Pipes, 1 mM MgSO4, 1 mM EGTAlarge numbers of multinucleated interphase cells (Table
[pH 6.8]) containing 0.1 mM GTP at 37C for 20 min followed by1; Figures 5 and 6). For example, the percentage of
centrifugation in a Beckman Coulter Optima MAX ultracentrifuge
multinucleated interphase cells at a 10 nM concentration (150,000	G, 30 min, 37C), aspiration of supernatants, and determi-
of each drug was 71.4  2.1% with SB-T-1213 and nation of supernatant protein concentration by the method of Brad-
59.8  8.2% with IDN5109. By comparison, the highest ford [25], with bovine serum albumin used as a standard; and (2)
tubulin (1.3–1.4 mg/ml) in assembly buffer containing 1 mM GTPproportion of multinucleated interphase cells observed
was polymerized in the presence of a range of drug concentrationswith paclitaxel was 37.7  11.5%, also at a concentra-
by warming from 0C to 30C in a Gilford Response recording spec-tion of 10 nM (20 hr incubation) [14]. Multinucleate cells
trophotometer equipped with a constant-temperature cuvet cham-
appear to be formed when mitotically blocked cells re- ber. Polymerization was quantitated by the measurement of turbidity
vert to interphase without completing cytokinesis [14, at 350 nm.
16]. In addition, the appearance of clusters of small
Electron Microscopyattached cells (Figure 6) is also indicative of faulty cytoki-
Tubulin (1.1–1.2 mg/ml) was assembled in the presence of drugnesis. Mitotic block, formation of aberrant spindles and
(1–10 M) in assembly buffer containing 0.1 mM GTP by warmingmultinucleated interphase cells, and induction of apo-
to 37C for 30 to 45 min. Samples for electron microscopy were fixed
ptosis all occur at concentrations of SB-T-1213 and by diluting 1:25 into 0.3% aqueous glutaraldehyde. After 30–60 s
IDN5109 that are similar to the concentrations that in- fixation, samples (4 l) were applied to parlodion- or carbon-coated
hibit cell proliferation, suggesting that, as with pacli- electron microscope grids for 30 s, then drawn off with torn filter
paper, followed sequentially by cytochrome C (1 mg/ml) for 20 s,taxel, their primary mechanism is blockage and disrup-
three drops H2O, and 1% uranyl acetate for 20 s, then viewed in ation of mitosis by suppression of microtubule dynamics.
JEOL 1230 at 80 KV. Results are from two independent experiments.
Significance
Cell Culture and Proliferation
HeLa S3 cells from epithelioid carcinoma of human cervix (American
SB-T-1213 and IDN5109 are semisynthetic, orally Type Culture Collection, Rockville, MD) were grown in monolayer
in tissue culture flasks or 35 mm six-well plates (Nunc, Rochester,available taxanes that are up to 400-fold more active
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NY; Falcon, Becton Dickinson, Lincoln Park, NJ; Corning, Corning,
NY) in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum (Sigma Chemical Co., St. Louis, MO) at 37C in
5% CO2, in the absence of antibiotics. Cells were plated in six-well
flat-bottom plates (Falcon, Lincoln Park, NJ) at a concentration of
105 cells/ml in complete medium. After 24 hr, the medium was re-
placed with media containing the test compounds (concentration
range 0.1–50 nM). Control cells were treated with vehicle alone.
After 20 hr of drug exposure, cells were washed twice and then
cultured in the absence of taxanes for an additional 48 hr. At this
time, viable adherent cells were counted four times (two experiments
by two independent operators) with a Diavert inverted microscope
(Leica, Wetzlar, Germany).
Clonogenic Assay
Approximately 0.8 	 103–1 	 103 cells were seeded into triplicate
25 cm2 flasks and incubated with a range of drug concentrations
(0.1-10 nM) for 20 hr. Flasks were then gently washed with PBS,
replaced with fresh medium, and incubated at 37C. After 10–12
days, cells were fixed and stained with 1% methylene blue in 70%
ethanol, and colonies were evaluated by visual count. The number
of colonies in treated cultures was expressed as a percentage of
the control cultures. All results represent means and standard devia-
tions from at least three independent experiments.
Immunofluorescence Microscopy
Subcultures of cells were seeded in 35 mm dishes containing #1.5
glass coverslips freshly coated with polylysine (50 g/ml, 2 hr, 37C,
followed by rinsing with sterilized deionized water). After drug incu-
bation, adherent cells were fixed in 10% formalin in PBS (2.7 mM
potassium chloride, 2.93 mM potassium phosphate monobasic, 137
mM sodium chloride, 14 mM dibasic sodium phosphate, 7.69 mM
sodium azide, 2 mM EGTA [pH 7.2–7.4]) at 25C for 10 min, then
transferred to 99.6% methanol, 2 mM ethylene glycol bis (B-amino-
ethyl ether)-N,N,NN-tetraacetic acid (20C) for 10 min. After
blocking of nonspecific antibody binding with normal goat serum,
fixed cells were stained for tubulin with a mouse monoclonal anti-
body (DM1A, Sigma), followed by fluorescein isothiocyanate-conju-
gated goat anti-mouse immunoglobulin G (Cappel, West Chester,
PA), and DAPI (4,6-diamidino-2-phenylindole) for chromosomes. a
Nikon Eclipse microscope with a 60	 oil immersion objective, a
Hamamatsu Orca II CCD camera, and a Metamorph Imaging system
were used to obtain photomicrographs by epifluorescence.
Mitotic Index
HeLa cells were seeded at a density of 2 	 104–4 	 104 cells/ml in
35 mm six-well plates. After 2 days, media were replaced with fresh
media containing compound. Twenty hr later, both attached and
floating cells were collected and combined (by trypsinization and
centrifugation), and cells were fixed and stained as described above,
except that cells were collected after each step by centrifugation
(3 min, clinical centrifuge) and cell pellets were resuspended in
fixative, stain, or washing buffer in the order described above. Mi-
totic indices were determined by counting cells by microscopy.
Apoptosis and DNA Analysis
HeLa cells were plated at a concentration of 105 cells/ml as de-
scribed above. After 24 hr, medium was replaced with fresh medium
containing either the compound to be tested or vehicle alone. After
incubation with compound (6–24 hr), cells were harvested, and nu-
clei were isolated and stained for DNA with 0.1% Na
citrate, 0.1%
NP40, 4 mM EDTA, and 50 g/ml propidium iodide [26] for 12 or
more hours at 4C. d-UTP labeling of DNA strand breaks was per-
formed with the Apodirect kit (Pharmingen, San Diego, CA) ac-
cording to the manufacturer’s directions. Flow cytometric DNA anal-
ysis was performed on 2 	 104 or more nuclei with a Facscan flow
cytometer (Becton Dickinson, San Jose, CA). DNA fluorescence wasFigure 8. Time Course for the Induction of Apoptosis by 5 nM SB-
T-1213
Results of a TUNEL assay (anti-BrDu FITC fluorescence) in combina-
tion with an assay of the amount of DNA, both by flow cytometry.
The time of drug incubation varied from 0 to 24 hr and is indicated is associated with the 4C region of DNA, indicating that apoptosis
at the top of each panel. The percentage of apoptotic cells is indi- occurred in cells blocked in G2/M or cells that reverted to interphase
cated in the lower right of each panel. The peak of apoptotic cells from G2/M without undergoing cytokinesis.
Effects of Novel Taxanes on Microtubules
101
collected in linear mode, and pulse signal processing was used to 15. Yvon, A.-M., Wadsworth, P., and Jordan, M.A. (1999). Taxol
suppresses dynamics of individual microtubules in living humanset a doublet discrimination gate. Cell cycle analysis was performed
in two independent experiments with a Multicycle software package tumor cells. Mol. Biol. Cell 10, 947–949.
16. Jordan, M.A., Wendell, K.L., Gardiner, S., Derry, W.B., Copp,(Phoenix, San Diego, CA).
H., and Wilson, L. (1996). Mitotic block induced in HeLa cells
by low concentrations of paclitaxel (Taxol) results in abnormalAcknowledgments
mitotic exit and apoptotic cell death. Cancer Res. 56, 816–825.
17. Parness, J., and Horwitz, S.B. (1981). Taxol binds to polymerizedWe gratefully acknowledge the technical assistance of Sean Nasri
tubulin in vitro. J. Cell Biol. 91, 479–487.and Kathryn Smith, as well as the expert purification of bovine brain
18. Diaz, J.F., and Andreu, J.M. (1993). Assembly of purified GDP-tubulin by Herb Miller. This work was supported by the National
tubulin into microtubules induced by taxol and taxotere: revers-Institutes of Health grants CA57291 (to M.A.J. and L.W.) and
ibility, ligand stoichiometry, and competition. Biochemistry 32,GM42798 (to I.O.).
2747–2755.
19. Caplow, M., Shanks, J., and Ruhlen, R. (1994). How taxol modu-References
lates microtubule disassembly. Biochemistry 269, 23399–
23402.1. Rowinsky, E. (1997). The development and clinical utility of the
20. Nogales, E., Wolf, S.G., Khan, I.A., Luduena, R.F., and Downing,taxane class of antimicrotubule chemotherapy agents. Annu.
K.A. (1995). Structure of tubulin at 6.5 A˚ and location of theRev. Med. 48, 353–374.
taxol-binding site. Nature 375, 424–427.2. Arbuck, S. (1995). Paclitaxel: current developmental ap-
21. Mogenson, M.M., and Tucker, J.B. (1990). Taxol influences con-proaches of the National Cancer Institute. Seminars in Oncology
trol of protofilament number at microtubule-nucleating sites inSuppl 15 22, 55–63.
Drosophila. J. Cell Sci. 97, 101–107.3. Ojima, I., Slater, J.C., Michaud, E., Kuduk, S.D., Bounaud, P.-Y.,
22. Andreu, J.M., Bordas, J., Diaz, J.F., Garcia de Ancos, J., Gil, R.,Vrignaud, P., Bissery, M.C., Veith, J.M., Pera, P., and Bernacki,
Medrano, F.J., Nogales, E., Pantos, E., and Towns-Andrews, E.R.J. (1996). Syntheses and structure-activity relationships of
(1992). Low resolution structure of microtubules in solution;the second-generation antitumor taxoids: exceptional activity
synchrotron x-ray scattering and electron microscopy of taxol-against drug-resistant cancer cells. J. Med. Chem. 39, 3889–
induced microtubules assembled from purified tubulin in com-3896.
parison with glycerol and map-induced microtubules. J. Mol.4. Distefano, M., Scambia, G., Ferlini, C., Gaggini, C., De Vincenzo,
Biol. 226, 169–184.R., Riva, A., Bombardelli, E., Ojima, I., Fattorossi, A., Panici, P.,
23. Jordan, M.A., and Wilson, L. (1998). Microtubules and actinet al. (1997). Anti-proliferative activity of a new class of taxanes
filaments: dynamic targets for cancer chemotherapy. Curr.(14beta-hydroxy-10-deacetylbaccatin III derivatives) on multi-
Opin. Cell Biol. 10, 123–130.drug-resistance-positive human cancer cells. Int. J. Cancer 72,
24. Toso, R.J., Jordan, M.A., Farrell, K.W., Matsumoto, B., and Wil-844–850.
son, L. (1993). Kinetic stabilization of microtubule dynamic insta-5. Ferlini, C., Distefano, M., Pierelli, L., Bonanno, G., Riva, A.,
bility in vitro by vinblastine. Biochemistry 32, 1285–1293.Bombardelli, E., Ojima, I., Mancuso, S., and Scambia, G. (1999).
25. Bradford, M.M. (1976). A rapid and sensitive method for theCytotoxic effects toward human hematopoietic progenitor cells
quantitation of microgram quantities of protein utilizing the prin-and tumor cell lines of paclitaxel, docetaxel, and newly devel-
ciple of protein-dye binding. Anal. Biochem. 72, 248–254.oped analogues IDN5109, IDN5111, and IDN5127. Oncol. Res.
26. Ferlini, C., Di Cesare, S., Rainaldi, G., Malorni, W., Samoggia,11, 471–478.
P., Biselli, R., and Fattorossi, A. (1996). Flow cytometric analysis6. Ferlini, C., Distefano, M., Pignatelli, F., Lin, S., Riva, A., Bombar-
of the early phases of apoptosis by cellular and nuclear tech-delli, E., Mancuso, S., Ojima, I., and Scambia, G. (2000). Antitu-
niques. Cytometry 24, 106–115.mour activity of novel taxanes that act as cytotoxic agents and
P-glycoprotein inhibitors at the same time. Br. J. Cancer 83,
1762–1768.
7. Polizzi, D., Pratesi, G., Tortoreto, M., Supino, R., Riva, A., Bom-
bardelli, E., and Zunino, F. (1999). A novel taxane with improved
tolerability and therapeutic activity in a panel of human tumor
xenografts. Cancer Res. 59, 1036–1040.
8. Nicoletti, M., Colombo, T., Rossi, C., Monardo, C., Stura, S.,
Zucchetti, M., Riva, A., Morazzoni, P., Donati, M., Bombardelli,
E., et al. (2000). IDN5109, a taxane with oral bioavailability and
potent antitumor activity. Cancer Res. 60, 842–846.
9. Vredenburg, M.R., Ojima, I., Veith, J., Pera, P., Kee, K., Cabral,
F., Sharma, A., Kanter, P., and Bernacki, R.J. (2001). Effects of
orally-active taxanes on P-glycoprotein modulation colon and
breast carcinoma resistance. J. Natl. Cancer Inst., 93, 1234–
1245.
10. Horwitz, S.B. (1992). Mechanism of action of taxol. Trends in
Pharmacol. Sci. 13, 134–136.
11. Wilson, L., Miller, H.P., Farrell, K.W., Snyder, K.B., Thompson,
W.C., and Purich, D.L. (1985). Taxol stabilization of microtubule
in vitro: dynamics of tubulin addition and loss at opposite micro-
tubule ends. Biochemistry 24, 5254–5262.
12. Derry, W.B., Wilson, L., and Jordan, M.A. (1995). Substoichio-
metric binding of taxol suppresses microtubule dynamics. Bio-
chemistry 34, 2203–2211.
13. Schiff, P.B., and Horwitz, S.B. (1980). Taxol stabilizes microtu-
bules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77,
1561–1565.
14. Jordan, M.A., Toso, R.J., Thrower, D., and Wilson, L. (1993).
Mechanism of mitotic block and inhibition of cell proliferation
by taxol at low concentrations. Proc. Natl. Acad. Sci. USA 90,
9552–9556.
